Norges Bank Aerovate Therapeutics, Inc. Transaction History

Norges Bank

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 09, 2022	SELL	$8.25 - $18.33 $837,416 - $1.86 Million	-101,505 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$9.14 - $21.54 $927,755 - $2.19 Million	101,505 New	101,505 $1.2 Million

1.63M

Ticker AVTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,448,100
Market Cap $65.5M
Description
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.